These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21305439)

  • 1. Primum non nocere? Why can't we use second generation ultrasound contrast agents for the examination of children?
    Piskunowicz M; Kosiak W; Irga N
    Ultraschall Med; 2011 Feb; 32(1):83-6. PubMed ID: 21305439
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous application of second-generation ultrasound contrast agents in children: a review of the literature.
    Piskunowicz M; Kosiak W; Batko T
    Ultraschall Med; 2012 Apr; 33(2):135-40. PubMed ID: 22161614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaphylactic shock with an ultrasound contrast agent.
    Coudray S; Fabre C; Aichoun I; Perez-Martin A
    J Med Vasc; 2017 Dec; 42(6):384-387. PubMed ID: 29203045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse effects associated with SonoVue use.
    Torzilli G
    Expert Opin Drug Saf; 2005 May; 4(3):399-401. PubMed ID: 15934848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced ultrasonography during liver surgery (Br J Surg 2004; 91: 1165-1167).
    de Groot MC; van Grootheest AC
    Br J Surg; 2005 Jan; 92(1):121-2; author reply 122. PubMed ID: 15635632
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adverse reactions to contrast media for magnetic resonance and echography].
    Simonetti G; Fanucci E; Masala S
    Radiol Med; 2004 Apr; 107(4 Suppl 1):34-5. PubMed ID: 15323320
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of Sulfur Hexafluoride Microbubbles in Sonography of Abdominal and Superficial Organs: Retrospective Analysis of 30,222 Cases.
    Tang C; Fang K; Guo Y; Li R; Fan X; Chen P; Chen Z; Liu Q; Zou Y
    J Ultrasound Med; 2017 Mar; 36(3):531-538. PubMed ID: 28072475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of contrast dobutamine stress echocardiography: a single center experience.
    Timperley J; Mitchell AR; Thibault H; Mirza IH; Becher H
    J Am Soc Echocardiogr; 2005 Feb; 18(2):163-7. PubMed ID: 15682054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echocardiography: fatal reactions to contrast agents.
    Prescrire Int; 2008 Dec; 17(98):245. PubMed ID: 19425266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic agents in a toxic research environment? The case of contrast ultrasound.
    Voci P; Pizzuto F
    J Cardiovasc Med (Hagerstown); 2009 Nov; 10(11):887-8. PubMed ID: 19584745
    [No Abstract]   [Full Text] [Related]  

  • 11. A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA.
    Seitz K; Strobel D
    Ultraschall Med; 2016 Jun; 37(3):229-32. PubMed ID: 27276056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaphylactic shock induced by sulphur hexafluoride in an individual with no history of heart disease: case report and literature review.
    Solivetti FM; Elia F; Musicco F; Bonagura AC; Di Leo N; Iera J; Drudi F
    Ultraschall Med; 2012 Dec; 33(6):597-8. PubMed ID: 22923262
    [No Abstract]   [Full Text] [Related]  

  • 13. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations.
    Piscaglia F; Bolondi L;
    Ultrasound Med Biol; 2006 Sep; 32(9):1369-75. PubMed ID: 16965977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse reactions after the use of SonoVue contrast agent: Characteristics and nursing care experience.
    Hu C; Feng Y; Huang P; Jin J
    Medicine (Baltimore); 2019 Nov; 98(44):e17745. PubMed ID: 31689827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse reactions after the use of sulphur hexafluoride (SonoVue) echo contrast agent.
    Geleijnse ML; Nemes A; Vletter WB; Michels M; Soliman OI; Caliskan K; Galema TW; ten Cate FJ
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):75-7. PubMed ID: 19145117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When you have eliminated the impossible, whatever remains, however improbable, must be the truth.
    Kaul S; Wei K
    Eur J Echocardiogr; 2009 Aug; 10(6):713-5. PubMed ID: 19671627
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety of intravenous application of second-generation ultrasound contrast agent in children: prospective analysis.
    Piskunowicz M; Kosiak W; Batko T; Piankowski A; Połczyńska K; Adamkiewicz-Drożyńska E
    Ultrasound Med Biol; 2015 Apr; 41(4):1095-9. PubMed ID: 25701526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced voiding urosonography with intravesical administration of a second-generation ultrasound contrast agent for diagnosis of vesicoureteral reflux: prospective evaluation of contrast safety in 1,010 children.
    Papadopoulou F; Ntoulia A; Siomou E; Darge K
    Pediatr Radiol; 2014 Jun; 44(6):719-28. PubMed ID: 24442338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.
    Claudon M; Dietrich CF; Choi BI; Cosgrove DO; Kudo M; Nolsøe CP; Piscaglia F; Wilson SR; Barr RG; Chammas MC; Chaubal NG; Chen MH; Clevert DA; Correas JM; Ding H; Forsberg F; Fowlkes JB; Gibson RN; Goldberg BB; Lassau N; Leen EL; Mattrey RF; Moriyasu F; Solbiati L; Weskott HP; Xu HX
    Ultraschall Med; 2013 Feb; 34(1):11-29. PubMed ID: 23129518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast enhanced ultrasound (CEUS) and off-label use (in children).
    Schreiber-Dietrich D; Dietrich CF
    Ultraschall Med; 2012 Jun; 33(3):295-6. PubMed ID: 22891364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.